1. Systematic review of drug bioavailability following gastrointestinal surgery

   • Manuela Moreno Santamaría
   • José Javier Arenas Villafranca
   • Pilar Utrilla Navarro

   Review 22 August 2018 Pages: 1531 - 1545

   

2. Pharmacodynamics and arteriovenous difference of intravenous naloxone in healthy volunteers exposed to remifentanil

   • Ida Tylleskar
   • Arne Kristian Skulberg
   • Ola Dale

   Pharmacodynamics 24 August 2018 Pages: 1547 - 1553

   

3. Impact of incorporating ABCB1 and CYP4F2 polymorphisms in a pharmacogenetics-guided warfarin dosing algorithm for the Brazilian population

   • Letícia C. Tavares
   • Nubia E. Duarte
   • Paulo Caleb Junior Lima Santos

   Pharmacogenetics 26 July 2018 Pages: 1555 - 1566

   

4. Clopidogrel utilization in patients with coronary artery disease and diabetes mellitus: should we determine CYP2C19*2 genotype?

   • Saoussen Chouchene
   • Rym Dabboubi
   • Mohsen Hassine

   Pharmacogenetics 03 August 2018 Pages: 1567 - 1574

5. The role of solute carrier (SLC) transporters in actinomycin D pharmacokinetics in paediatric cancer patients

   • Hannah Yejin Kim
   • Gareth J Veal
   • Alan V Boddy

   Pharmacogenetics 30 August 2018 Pages: 1575 - 1584

   

6. Simulation-based suggestions to improve ibuprofen dosing for patent ductus arteriosus in preterm newborns

   • Robert B. Flint
   • Rob ter Heine
   • Sinno H. P. Simons

   Pharmacokinetics and Disposition Open access 28 July 2018 Pages: 1585 - 1591

   

7. Siponimod pharmacokinetics, safety, and tolerability in combination with rifampin, a CYP2C9/3A4 inducer, in healthy subjects

   • Anne Gardin
   • Cathy Gray
   • Kasra Shakeri-Nejad

   Pharmacokinetics and Disposition 13 August 2018 Pages: 1593 - 1604

   

8. A pharmacokinetic drug-drug interaction study between pregabalin and tramadol in healthy volunteers

   • Soyoung Lee
   • Yun Kim
   • Seonghae Yoon

   Pharmacokinetics and Disposition 22 August 2018 Pages: 1605 - 1613

   

9. Voriconazole greatly increases the exposure to oral buprenorphine

   • Mari Fihlman
   • Tuija Hemmilä
   • Teijo I. Saari

   Pharmacokinetics and Disposition 30 August 2018 Pages: 1615 - 1622

   

10. Chronic hypnotic use at 10 years—does the brand matter?

    • Yochai Schonmann
    • Or Goren
    • Shlomo Vinker

    Pharmacoepidemiology and Prescription 08 August 2018 Pages: 1623 - 1631

    

11. The associations of geriatric syndromes and other patient characteristics with the current and future use of potentially inappropriate medications in a large cohort study

    • Dana Clarissa Muhlack
    • Liesa Katharina Hoppe
    • Ben Schöttker

    Pharmacoepidemiology and Prescription 29 August 2018 Pages: 1633 - 1644

12. Acquired drug-induced long QTc: new insights coming from a retrospective study

    • Renato De Vecchis
    • Carmelina Ariano
    • Michel Noutsias

    Pharmacoepidemiology and Prescription 15 August 2018 Pages: 1645 - 1651

    

13. Risk factors for stroke and choice of oral anticoagulant in atrial fibrillation

    • Lars J. Kjerpeseth
    • Hanne Ellekjær
    • Eva Skovlund

    Pharmacoepidemiology and Prescription 16 August 2018 Pages: 1653 - 1662

    

14. Reconsidering clinical pharmacology frameworks as a necessary strategy for improving the health care of patients: a systematic review

    • Davide Grisafi
    • Alessandro Ceschi
    • Francesco Scaglione

    Point of View 14 July 2018 Pages: 1663 - 1670

    

15. Disposition of ceftobiprole during continuous venous-venous hemodiafiltration (CVVHDF) in a single critically ill patient

    • Pier Giorgio Cojutti
    • Maria Merelli
    • Federico Pea

    Letter to the Editor 10 August 2018 Pages: 1671 - 1672

    

16. Vomiting and constipation associated with tramadol and codeine: a comparative study in VigiBase®

    • François Montastruc
    • Justine Benevent
    • Jean-Louis Montastruc

    Letter to the Editor 10 August 2018 Pages: 1673 - 1674

17. Acknowledgment to referees

    Acknowledgments 29 October 2018 Pages: 1675 - 1675